(Q38113521)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Silvia Piantoni

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Franco Franceschini

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

8

Angela Tincani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1

Laura Andreoli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

3

Cecilia Nalli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

Rossella Reggia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

6

Francesca Dall'Ara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

1 reference

1 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

Current Rheumatology Reports

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23754504%20AND%20SRC:MED&resulttype=core&format=json

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Ethnic and geographical variation in antiphospholipid (Hughes) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

IgA antiphospholipid antibodies are an independent risk factor for thromboses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Anticardiolipin antibodies in Behçet's disease: a reassessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Isolated elevation of IgA anti-beta2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: a case series of five patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

IgA antibodies to beta2-glycoprotein I and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-013-0343-1

Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI

21 January 2018

1 reference

12 December 2020

Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis

1 reference

12 December 2020

Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus

1 reference

12 December 2020

Anticardiolipin antibodies in uveitis

1 reference

12 December 2020

Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-Beta 2-glycoprotein I antibody isotype and IgG subclass in antiphospholipid syndrome patients

1 reference

12 December 2020

Increased transforming growth factor-beta (TGF-beta)-secreting T cells and IgA anti-cardiolipin antibody levels during acute stage of childhood Henoch-Schönlein purpura

1 reference

12 December 2020

Clinical Significance of Anticardiolipin Antibodies in Patients with Systemic Sclerosis

1 reference

12 December 2020

Association of IgA Anti-ß2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus

1 reference

12 December 2020

Catastrophic antiphospholipid syndrome associated with anti-beta-2-glycoprotein I IgA

1 reference

12 December 2020

Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus

1 reference

12 December 2020

Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.

1 reference

12 December 2020

Isotypes of anti-beta2-glycoprotein I antibodies: association with thrombosis in patients with systemic lupus erythematosus

1 reference

12 December 2020

Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion

1 reference

12 December 2020

'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

1 reference

12 December 2020

High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.

1 reference

12 December 2020

Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review

1 reference

12 December 2020

Elevated IgA and IgM anticardiolipin antibodies in acute Kawasaki disease

1 reference

12 December 2020

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

1 reference

12 December 2020

Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I

1 reference

12 December 2020

IgA-class anti-beta2-glycoprotein I in women with unexplained recurrent spontaneous abortion

1 reference

12 December 2020

Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study

1 reference

12 December 2020

IgA anticardiolipin antibodies--relation with other antiphospholipid antibodies and clinical significance.

1 reference

12 December 2020

IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis

1 reference

12 December 2020

Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis

1 reference

12 December 2020

Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome

1 reference

12 December 2020

IgA anticardiolipin and anti-beta2-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-beta2-glycoprotein I autoantibodies and metabolic syndrome

1 reference

12 December 2020

Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.

1 reference

12 December 2020

High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis

1 reference

12 December 2020

The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.

1 reference

12 December 2020